nach oben

Erschienen in:

Open Access 01.12.2022 | Research

Pulse pressure is associated with cognitive performance in Japanese non-demented population: a cross-sectional study

verfasst von: Ryo Mizuhara, Shingo Mitaki, Masahiro Takamura, Satoshi Abe, Keiichi Onoda, Shuhei Yamaguchi, Atsushi Nagai

Erschienen in: BMC Neurology | Ausgabe 1/2022

Abstract

Background

Growing evidence suggests that vascular risk factors, especially hypertension, relate not only to cardiovascular disease but also to cognitive impairment. However, the impact of pulse pressure on cognitive function remains controversial. In this study, we evaluated the associations between pulse pressure and cognitive function in a Japanese health examination cohort using propensity matching analysis.

Methods

We examined 2,546 individuals with a mean age of 60.8 ± 10.3 years who voluntarily participated in health examination. Clinical variables included pulse pressure, and brain magnetic resonance imaging (MRI). We divided the participants into the high and low pulse pressure groups with a pre-defined cut-off value of 65 mmHg and evaluated their physical examination data, cognitive functions including Okabe’s test, Kohs’ test, and silent brain lesions using propensity matching. To clarify whether pulse pressure and blood pressure have different implications for cognitive function, a mediating analysis was also conducted.

Results

From the 2,546 subjects, 439 (17.2%) were in the high PP group. The propensity matching algorithm produced 433 pairs of patients with similar propensities. Higher pulse pressure corresponded to lower Okabe and Kohs’ scores (44.3 ± 7.1 vs 42.7 ± 7.5; p = 0.002, 97.9 ± 18.0 vs 95.0 ± 18.1 p = 0.019, respectively). The relationship between pulse pressure and cognitive impairment was not significantly mediated by systolic blood pressure. We observed no significant associations between silent brain lesions and pulse pressure.

Conclusion

High pulse pressure was associated with lower cognitive performance without systolic blood pressure mediation in Japanese subjects without dementia.

Additional file 1: Supplemental Table. Physical, brain, and cognitive assessment in participants with lower and higher pulse pressure before matching.

Supplementary Information

The online version contains supplementary material available at https://doi.org/10.1186/s12883-022-02666-6.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

MRI

Magnetic resonance imaging

Pulse pressure

SBP

Systolic blood pressure

DBP

Diastolic blood pressure

Blood pressure

CMB

Cerebral microbleed

PVH

Periventricular hyperintensity

WMH

White matter hyperintensity

SWML

Subcortical white matter hyperintensity

FAB

Frontal assessment battery

SDS

Self-rating Depression Scale

SBI

Silent brain infarct

Background

Pulse pressure (PP) is calculated as the difference between systolic (SBP) and diastolic blood pressure (DBP) and is considered a measure of arterial stiffness. Recently, high pulse pressure was linked to increased risk of cardiovascular disease [1]. Moreover, because changes in PP can occur in accordance with both SBP and DBP fluctuations, PP might be more useful than blood pressure (BP) for predicting cardiovascular risks [2].

Vascular risk factors, especially hypertension, are known to be related not only to cardiovascular disease but also to cognitive impairment [3]. Since hypertension is a major risk factor for cerebrovascular disease, it may also be associated with vascular dementia. Moreover, recent studies suggests that vascular risk factors influence the clinical course and pathophysiology of Alzheimer’s disease [4] and the association between BP and cognitive impairment has been observed in several epidemiological studies [5]. Given that PP is a better clinical indicator of functional arterial changes than BP itself, it might be related to the pathogenesis of cognitive impairment. However, there is conflicting evidence about the association of cognitive performance with PP. Several studies have suggested that high PP is associated with worse cognitive performance [6‐9]. However, opposite results have also been demonstrated in some studies [10, 11]. There are indications that an age effect could partly explain these conflicting findings.

In this study, we evaluated the associations between PP and cognitive function in a well-characterized Japanese health examination cohort using two complementary statistical approaches: propensity matching and multivariate regression.

Methods

Study population

We studied a total of 2,546 individuals (1,386 men and 1160 women) with a mean age of 60.8 ± 10.3 years (range 27–95). All participants voluntarily underwent the brain health check-up at the Shimane Health Science Center between April 2004 and July 2015. The assessment included medical history, neurological examination by an experienced neurologist, BP measurement, neuropsychological testing, and magnetic resonance imaging (MRI) scans of the head. The criteria for subject exclusion were as follows: any history of neurological or psychiatric conditions, such as cerebrovascular diseases including transient ischemic attack, dementia, depression, or other psychiatric diseases, and missing data. All individuals provided informed consent to participate in this study, which was approved by the institutional ethics committee.

Physical examination

BP was measured twice in the brachial artery of seated participants using an automatic electronic device after 5 min of rest. The mean of the two measurements was used. Hypertension was defined as having a SBP > 140 mmHg, a DBP > 90 mmHg, or a history of hypertension with antihypertensive therapy based on the Guidelines from the 2019 Japanese society of hypertension [12]. Diabetes mellitus was defined by fasting glucose level exceeding 126 mg/dl, random glucose level exceeding 200 mg/dl, an HbA1c level exceeding 6.5%, and/or a medical or self-reported history of diabetes or treatment with oral antidiabetic drugs or insulin. Dyslipidemia was defined by serum triglyceride level exceeding 150 mg/dl, high-density lipoprotein cholesterol level below 40 mg/dl, or a medical history of dyslipidemia.

Brain imaging

Brain infarction was defined as a focal hyperintense lesion ≥ 3 mm in diameter on T2-weighted images. Fluid-attenuated inversion recovery images were used to differentiate infarcts from enlarged perivascular spaces. Cerebral microbleeds (CMBs) were defined as homogenous round foci of signal loss on gradient-echo T2*-weighted images that were 2–10 mm in diameter. Periventricular hyperintensities (PVHs) and white matter hyperintensities (WMHs) were evaluated based on their distinct subcortical distributions on fluid-attenuated inversion recovery images. PVH and subcortical white matter hyperintensity (SWML) were evaluated separately based on their distinct subcortical distributions on the fluid-attenuated inversion recovery image, because PVH was observed adjacent to the ventricles and SWML was observed separately from the ventricles. PVH was graded on a scale of 0 – 4, as described previously [13]. SWML was graded on a scale of 0 – 3 according to the Fazekas grading scheme [14]. For statistical purposes, PVH and SWML grades were dichotomized; we defined PVH grades 0–2 as ‘PVH–’ and grades 3–4 as ‘PVH + ’; similarly, SWML grades 0–1 were defined as ‘SWML–’, and grades 2–3 were termed ‘SWML + ’. CMBs were identified as 2–10 mm diameter rounded hypointense lesions on T2*-weighted images. All MRI findings were evaluated separately by an experienced neurologist and a radiologist who were blinded to the patient profiles. When their opinions were inconsistent, a second neurologist was consulted. An interrater study for evaluating MRI lesions was performed blindly by two independent raters.

Cognitive function evaluation

General cognitive function was assessed using Okabe’s Intelligence Scale (Okabe’s test) [15], which is a shortened and modified Wechsler Adult Intelligence Scale-Revised for the Japanese aged population and includes orientation, semantic memory, calculation, forward and backward digit span, and paired association memory. The test scores a total of 60 points, and its reliability has been previously validated [16]. There was a significant correlation between Okabe’s test and the Mini Mental State Examination (MMSE) [15, 16]. The Kohs’ block design test (Kohs’ test) is a popular bedside screening test for constructional function and cognitive function. The subjects were shown cards with a variety of colored designs and were asked to reproduce them using a set of colored blocks, yielding an intelligence quotient [17]. This test assessed the visuospatial ability in addition to executive function. Frontal function was estimated using the frontal assessment battery (FAB) [18]. Affective functions were evaluated using the Self-rating Depression Scale (SDS) [19] and the Japanese version of the Apathy Scale [20].

Statistics

In order to examine the effect of PP on several physical and functional assessments, we applied two statistical approaches: 1) a comparison between high and low PP groups with propensity score matching, and 2) a multiple regression analysis. In the former approach, we divided all subjects into high and low PP groups with a pre-defined cut-off value of 65 mmHg [21]. To avoid possible confounding effects caused by grouping with PP values, we used propensity score matching in this study. To obtain the propensity score, we assigned these two groups to the explanatory variable and performed logistic regression analysis after correcting for the following covariates suggested to influence pulse pressure: age, sex, and medical history of hypertension, diabetes mellitus, and dyslipidemia. Propensity score matching was performed using the following algorithm: 1:1 ratio nearest-neighbor match with ± 0.01 caliper and no replacement. The balance diagnostics were tested using standardized difference (d), calculated as following [22]. For a continuous covariate,

$$d=\frac{{\overline{x} }_{highPP }- {\overline{x} }_{lowPP }}{\sqrt{\frac{{var}_{highPP}+ {var}_{lowPP}}{2}}}$$

where ${\overline{x} }_{group}$ and ${var}_{group}$ denote the mean and sample variance of the covariate in each group, respectively. For categorical or dichotomous covariates,

$$d=\frac{\left({\widehat{p}}_{highPP}- {\widehat{p}}_{lowPP}\right)}{\sqrt{\frac{{\widehat{p}}_{highPP}\left(1-{\widehat{p}}_{highPP}\right)+ {\widehat{p}}_{lowPP}\left(1-{\widehat{p}}_{lowPP}\right)}{2}}}$$

where ${\widehat{p}}_{group}$ denote the mean prevalence of the dichotomous variable in each group.

Physical examination results, silent brain lesions, and cognitive functions were compared between the high and low PP groups, before propensity matching, using a two-sided Student’s t-test for continuous variables and χ² analyses for categorical variables. After matching, two-sided paired t-test and McNemar test were used for the group comparison, respectively. To evaluate whether the association between PP and cognitive function was affected by SBP, mediation analysis was performed. In the mediation analysis, the significance of the effect was tested using Sobel’s delta method. None of the control variables were included in the mediation model.

As an additional analytical approach, we conducted multiple regression analyses for cognitive function variables. In the initial propensity score matching approach, the two PP groups were generated by dichotomizing a continuous variable with a cut-off value. Although the applied cut-off value has been used in prior studies [21], this procedure is criticized because it can induce underpower [23]. In this regression analyses, PP value was used as a continuous explanatory variable and all study samples were subjected to the analysis. In the multiple regression model, PP, SBP, age, sex, medical history of hypertension, diabetes mellitus, and dyslipidemia were included as explanatory variables. SBP was included to determine the variable related to the dependent variable. Dependent variables were selected based on the result of the propensity matching approach.

All statistical analyses were performed using IBM SPSS Statistics ver. 22 (SPSS, Inc.). Differences were considered significant at p < 0.05.

Results

Physical examination data

Population statistics of the PP groups were characterized before propensity matching as presented in Table 1. Among 2,546 participants, 439 (17.2%) were in the high PP group. Individuals in the high PP group were older (p < 0.001), and were more often females, compared with the low PP group (p = 0.003). Subjects with higher PP had hypertension (p < 0.001) and diabetes (p < 0.001) significantly more often. However, there was no significant difference in the prevalence of dyslipidemia between the groups. The propensity matching algorithm produced 433 pairs of patients with similar propensities. The standardized difference scores of the controlled variables were small enough (d < 0.1). In the propensity-matched dataset, the SBP and DBP were higher in persons with high PP than in those with low PP (p < 0.05).

Table 1

Baseline characteristics before and after propensity matching

Characteristics	Before matching			After matching
	Pulse pressure (mmHg)			Pulse pressure (mmHg)
	Lower (< 65)	Higher (≧65)	P value	Lower (< 65)	Higher (≧65)	Balance statistics
No. of subjects	2017	439		433	433
Age (year)	59.8 (10.4)	65.4 (8.5)	< 0.001	64.9 (8.6)	65.4 (8.4)	0.030
Female (%)	46.6	51.9	0.003	50.3	51.5	-0.023
Hypertension (%)	32	59.2	< 0.001	60.2	58.9	-0.028
Diabetes (%)	9	14.1	< 0.001	13.4	13.6	0.007
Hyperlipidemia (%)	48.3	50.8	0.087	52	50.6	-0.028

Brain imaging results

The prevalence of silent brain infarct (SBI), PVH, SWML, and CMBs is shown for each group after propensity matching in Table 2. For information, the metrics of before matching are presented in Suppremental table. Before matching, subjects with higher PP had more SBIs (p < 0.001) and worse PVH (p < 0.001) and SWML (p < 0.001) scores (Supplemental Table). In the propensity-matched sample, there were no significant differences in the occurrence of silent lesions between the two groups.

Table 2

Physical, brain, and cognitive assessment in participants with lower and higher pulse pressure after matching

	Pulse pressure (mmHg)		P value^a
	Lower (< 65)	Higher (≧65)	P value^a
Systolic BP (mmHg)	127.5(14.2)	149.9(14.1)	< 0.001
Diastolic BP (mmHg)	73.7(11.4)	75.9(11.5)	0.005
PP (mmHg)	53.9(7.6)	74.0(7.3)	< 0.001
SBI	35 (8.1)	45 (10.4)	0.282
PVH grade≧3	49 (11.3)	49 (11.3)	1.000
SWML	127 (29.3)	143 (33.0)	0.217
CMBs	44 (9.9)	32 (7.4)	0.182
Okabe’s test (shortened version of WAIS-R)	44.3 (7.1)	42.7 (7.5)	0.001
Information	16.2 (2.8)	15.9 (2.7)	0.118
Mental control	11.9 (3.8)	11.1 (4.1)	0.001
Digit span	9.0 (1.4)	8.8 (1.5)	0.011
Assoc. learning	7.1 (3.0)	7.0 (3.1)	0.492
Kohs’ test	97.9 (18.0)	95.0 (18.1)	0.010
FAB	15.8 (1.5)	15.7 (1.5)	0.165
SDS	34.4 (7.9)	33.8 (7.7)	0.229
Apathy scale	10.9 (5.4)	11.2 (5.7)	0.453

Abbreviation: BP Blood Pressure, SBI Silent Brain Infarction, PVH Periventricular Hyperintensity, SWML Subcortical White Matter Hyperintensity, CMBs Cerebral Microbleeds, WAIS-R Wechsler Adult Intelligence Scale-Revised, Assoc. Learning Association Learning, FAB Frontal Assessment Battery, SDS Self-rating Depression Scale

Values are mean (SD) or n (%). ^a p-value of paired t-test or McNemar test

Cognitive functions

The cognitive function scores for the two groups before and after propensity matching are presented in Supplemental Table and Table 2, respectively. Before matching, the high PP group showed lower cognitive function scores in Okabe’s test (p < 0.001), Kohs’ test (p < 0.001), FAB (p < 0.001), and SDS (p = 0.014) compared with the low PP group (Supplemental Table). After matching, the Okabe scores (especially mental control and digit span) and Kohs’ scores were still lower in the high PP group than in the low PP group (p < 0.05). Apathy scale scores did not show any difference between the groups before and after matching. To investigate whether the relationship between PP and cognitive function was affected by SBP, mediation analysis was performed. As shown in Fig. 1a the direct effect of PP on Okabe’s test was significant (effect size of -0.093), while the SBP mediated effect of PP on Okabe’s test was not significant. Similarly, as shown in Fig. 1b, the direct effect of PP on Kohs’ test was significant (effect size of -0.312), while the SBP mediated effect of PP on Kohs’ test was not significant. Thus, PP was significantly associated with Okabe’s and Kohs’ tests, but was not mediated by SBP (Table 3).

Table 3

The relationship between pulse pressure and cognitive function tested by mediation analysis

					95% Confidence Interval
	Estimate	Std. Error	Z value	P value	Lower	Upper
Okabe
Direct effects (PP → Okabe)	-0.093	0.031	-2.983	0.003	-0.153	-0.032
Indirect effects (PP → SBP → Okabe)	0.010	0.024	0.435	0.664	-0.037	0.058
Total effects (PP → Okabe)	-0.082	0.02	-4.181	< 0.001	-0.121	-0.044
Kohs
Direct effects (PP → Kohs)	-0.312	0.077	-4.072	< 0.001	-0.462	-0.162
Indirect effects (PP → SBP → Kohs)	0.109	0.059	1.839	0.066	-0.007	0.226
Total effects (PP → Kohs)	-0.203	0.049	-4.172	< 0.001	-0.298	-0.107

Abbreviation: PP Pulse Pressure, SBP Systolic Blood Pressure

Additional multiple linear regression analysis

The relationship between the cognitive function scores and PP was also examined by multiple linear regression analysis using the whole study sample. The detailed results are presented in Table 4. The effect of PP on Okabe’s test and Kohs’ test was significant, whereas the effect of SBP was not.

Table 4

Multiple linear regression analysis of cognitive function

Dependent variable	Independent variables				95% Confidence Interval
Dependent variable	Independent variables	B	Std. Error	P value	Lower	Upper	VIF
Okabe	(constant)	58.506	1.427	< 0.001	55.708	61.305
(R² adjusted = 0.103)	Age	-0.195	0.014	< 0.001	-0.223	-0.167	1.194
	Sex	0.076	0.289	0.793	-0.490	0.642	1.117
	Hypertension	-0.336	0.317	0.290	-0.958	0.286	1.246
	Diabetes	-0.079	0.473	0.867	-1.006	0.848	1.046
	Hyperlipidemia	-0.014	0.275	0.960	-0.554	0.526	1.021
	Systolic BP	0.017	0.013	0.189	-0.008	0.043	2.711
	PP	-0.720	0.019	< 0.001	-0.109	-0.034	2.633
Kohs	(constant)	167.590	3.262	< 0.001	161.193	173.987
(R² adjusted = 0.284)	Age	-0.852	0.033	< 0.001	-0.917	-0.788	1.194
	Sex	-4.654	0.660	< 0.001	-5.948	-3.360	1.117
	Hypertension	-0.402	0.725	0.579	-1.824	1.019	1.246
	Diabetes	-0.560	1.081	0.604	-2.679	1.558	1.046
	Hyperlipidemia	-0.695	0.630	0.270	-1.930	0.539	1.021
	Systolic BP	-0.009	0.030	0.767	-0.067	0.049	2.711
	PP	-0.104	0.043	0.017	-0.189	-0.019	2.633

Abbreviation: VIF Variance Inflation Factor

Discussion

In this study, we revealed that higher PP was associated with lower cognitive performance. Furthermore, our results indicate that these relationships were not mediated by SBP. However, we observed no significant relationship between PP and silent brain lesions.

To date, studies on the association between PP and cognitive function have inconsistent results, stemming mainly from the difference in age of the study populations. The subjects, who participated in our study, were individuals with an average age of 60 years; therefore, in this study, the impact of PP on cognitive performance of middle-aged populations wasfocused. Recently, consistent with our study, Zang et al. [6] in a study on 3009 subjects from the SPRINT-MIND revealed that higher PP was associated with poor cognitive performance. Similarly, Obisesan et al. [7], in a total of 3129 subjects from the Third National Health and Nutrition Examination Survey revealed that higher PP was associated with worse MMSE performance. Similar relationship between PP and cognitive function has also been demonstrated in longitudinal studies. Peters et al. [8], in a total of 3337 subjects from the HYVET cohort, revealed that higher PP was associated with an increased risk of dementia during a 2.2-year of follow-up. Similarly, other studies have revealed that PP predicts cognitive decline in community-dwelling individuals [9, 24]. On the other hand, studies in very old individuals oppose the findings of this study. Molander et al. [10] demonstrated that higher PP related to better cognitive function in a cohort of 476 participants aged 85 years or more. Similarly, Sabayan et al. [11] revealed that higher PP associates with lower annual declines in MMSE scores during the 3.2-year follow-up in the 572-participant cohort of the Leiden 85-plus Study. In the eldest, impaired vascular system function can result in low PP and hypoperfusion in the brain, which in turn may induce cognitive impairment. Further studies are needed to evaluate these age-dependent differences in the relationship between PP and cognitive function.

Interestingly, the relationship between PP and Okabe’s and Kohs’ tests was not mediated by SBP, even though SBP was strongly associated with PP and was previously linked with cognitive dysfunction [25, 26]. PP could be a surrogate marker of arterial stiffness [27] that represents the chronic effects of hypertension other than BP itself. Our results are consistent with previous reports showing that PP was a better predictor of cognitive impairment than BP [28, 29]. Thus, hypertension-associated changes in the brain might be detected by measures of arterial stiffness, such as PP, rather than SBP. Increased PP might represent diminished regulatory functions of vessels against pulsate blood flow, making the brain tissues more susceptible to direct injury.

In this study, PP was not associated with the prevalence of silent brain lesions, including SBI, PVH, SWML, and CMBs, indicating that PP might affect cognitive function independent of the burden of arteriosclerotic cerebral small vessel-related lesions. In previous reports, the relation between arterial stiffness the amount of Aβ deposition in the brain was suggested [30, 31]. A previous study revealed that arterial stiffness measured with peripheral pulse wave velocity significantly associates with the extent of Aβ deposition and the accumulation of Aβ in the brain over 2 years in elderly adults without dementia [30]. Since an increase in PP is recognized as arterial stiffness, it is speculated that increased PP causes decreased flow of brain interstitial fluid, thereby leading to decreased Aβ clearance along the perivascular space [32, 33] and accelerating the formation of Aβ plaques.

This study has several limitations. First, the cross-sectional study design limits causal inferences. More importantly, the application of the propensity score matching in this scenario (assuming the individual’s PP-level as an exposure) is not typical to the original concept of this analysis. Second, the subjects were recruited from a health examination cohort that might not properly represent the entire population of Japan. Third, the association between cognitive performance and brain lesions was not evaluated. Finally, we could not exclude the possibility of residual confounding by unmeasured determinants, such as medication, diet, or physical activity, which could have an effect on PP.

Conclusion

In conclusion, our findings suggest that PP has a significant relationship with cognitive function among non-demented Japanese individuals. Higher PP was associated with lower general intelligence and visuospatial ability without SBP mediation. Future longitudinal studies are needed to explore the association between PP and cognitive decline in a representative sample of the Japanese population.

Acknowledgements

Not applicable.

Declarations

All procedures involving human participants were performed in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Bioethics Committee of Shimane University (No. 20160217–1). All individuals provided informed consent to participate.

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Supplemental Table. Physical, brain, and cognitive assessment in participants with lower and higher pulse pressure before matching.

de Simone G, Roman MJ, Alderman MH, Galderisi M, de Divitiis O, Devereux RB. Is high pulse pressure a marker of preclinical cardiovascular disease? Hypertension. 2005;45:575–9. https://doi.org/10.1161/01.HYP.0000158268.95012.08.CrossRefPubMed

Madhavan S, Ooi WL, Cohen H, Alderman MH. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension. 1994;23:395–401. https://doi.org/10.1161/01.hyp.23.3.395.CrossRefPubMed

Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the lancet commission. Lancet. 2020;396:413–46. https://doi.org/10.1016/S0140-6736(20)30367-6.CrossRefPubMedPubMedCentral

de la Torre JC. Is Alzheimer’s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol. 2004;3:184–90. https://doi.org/10.1016/S1474-4422(04)00683-0.CrossRefPubMed

Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005;4:487–99. https://doi.org/10.1016/S1474-4422(05)70141-1.CrossRefPubMed

Zang J, Shi J, Liang J, Zhang X, Wei W, Yao C, et al. Pulse pressure, cognition, and white matter lesions: a mediation analysis. Front Cardiovasc Med. 2021;8:654522. https://doi.org/10.3389/fcvm.2021.654522.CrossRefPubMedPubMedCentral

Obisesan TO, Obisesan OA, Martins S, Alamgir L, Bond V, Maxwell C, et al. High blood pressure, hypertension, and high pulse pressure are associated with poorer cognitive function in persons aged 60 and older: the third national health and nutrition examination survey. J Am Geriatr Soc. 2008;56:501–9. https://doi.org/10.1111/j.1532-5415.2007.01592.x.CrossRefPubMedPubMedCentral

Peters R, Beckett N, Fagard R, Thijs L, Wang JG, Forette F, et al. Increased pulse pressure linked to dementia: further results from the hypertension in the Very Elderly Trial - HYVET. J Hypertens. 2013;31:1868–75. https://doi.org/10.1097/HJH.0b013e3283622cc6.CrossRefPubMed

Ogunniyi A, Lane KA, Baiyewu O, Gao S, Gureje O, Unverzagt FW, et al. Hypertension and incident dementia in community-dwelling elderly Yoruba Nigerians. Acta Neurol Scand. 2011;124:396–402. https://doi.org/10.1111/j.1600-0404.2011.01491.x.CrossRefPubMedPubMedCentral

10.

Molander L, Gustafson Y, Lövheim H. Longitudinal associations between blood pressure and dementia in the very old. Dement Geriatr Cogn Disord. 2010;30:269–76. https://doi.org/10.1159/000320252.CrossRefPubMed

11.

Sabayan B, Oleksik AM, Maier AB, van Buchem MA, Poortvliet RK, de Ruijter W, et al. High blood pressure and resilience to physical and cognitive decline in the oldest old: the Leiden 85-plus Study. J Am Geriatr Soc. 2012;60:2014–9. https://doi.org/10.1111/j.1532-5415.2012.04203.x.CrossRefPubMed

12.

Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42:1235–481. https://doi.org/10.1038/s41440-019-0284-9.CrossRefPubMed

13.

Kobayashi S, Okada K, Koide H, Bokura H, Yamaguchi S. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke. 1997;28:1932–9. https://doi.org/10.1161/01.str.28.10.1932.CrossRefPubMed

14.

Fazekas F, Niederkorn K, Schmidt R, Offenbacher H, Horner S, Bertha G, et al. White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. Stroke. 1988;19:1285–8. https://doi.org/10.1161/01.str.19.10.1285.CrossRefPubMed

15.

Okabe S. Simple intelligence assessment scale. Jpn J Clin Psychiat. 1988;17:55–61.

16.

Fukunishi I, Okabe S, Nakagawa T, Hosokawa K. The assessment of intelligence function of aged chronic schizophrenia. Jpn J Psychiatry Neurol. 1990;44:503–9. https://doi.org/10.1111/j.1440-1819.1990.tb01623.x.CrossRefPubMed

17.

Wigg CM, Duro LA. The Kohs’ blocks test as an important instrument to investigate the visuo-spatial impairments in myotonic dystrophy Part I. Quantitative and qualitative analysis. Arq Neuropsiquiatr. 1999;57:547–55. https://doi.org/10.1590/s0004-282x1999000400002.CrossRefPubMed

18.

Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000;55:1621–6. https://doi.org/10.1212/wnl.55.11.1621.CrossRefPubMed

19.

Zung WW. A Self-Rating Depression Scale. Arch Gen Psychiatry. 1965;12:63–70. https://doi.org/10.1001/archpsyc.1965.01720310065008.CrossRefPubMed

20.

Okada KK, Suyama S, Yamagata S. ssessment of motivational loss in poststroke patients using the Japanese version of Starkstein’s Apathy Scale (in Japanese). Jpn J Stroke. 1998;20:318–27 KS: Aoki Shoten.CrossRef

21.

Nation DA, Edmonds EC, Bangen KJ, Delano-Wood L, Scanlon BK, Han SD, et al. Pulse pressure in relation to tau-mediated neurodegeneration, cerebral amyloidosis, and progression to dementia in very old adults. JAMA Neurol. 2015;72:546–53. https://doi.org/10.1001/jamaneurol.2014.4477.CrossRefPubMedPubMedCentral

22.

Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46:399–424. https://doi.org/10.1080/00273171.2011.568786.CrossRefPubMedPubMedCentral

23.

Naggara O, Raymond J, Guilbert F, Roy D, Weill A, Altman DG. Analysis by categorizing or dichotomizing continuous variables is inadvisable: an example from the natural history of unruptured aneurysms. AJNR Am J Neuroradiol. 2011;32:437–40. https://doi.org/10.3174/ajnr.A2425.CrossRefPubMedPubMedCentral

24.

Waldstein SR, Rice SC, Thayer JF, Najjar SS, Scuteri A, Zonderman AB. Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore longitudinal study of aging. Hypertension. 2008;51:99–104. https://doi.org/10.1161/HYPERTENSIONAHA.107.093674.CrossRefPubMed

25.

Guo Z, Fratiglioni L, Winblad B, Viitanen M. Blood pressure and performance on the mini-mental state examination in the very old. Cross-sectional and longitudinal data from the Kungsholmen project. Am J Epidemiol. 1997;145:1106–13. https://doi.org/10.1093/oxfordjournals.aje.a009073.CrossRefPubMed

26.

Tzourio C, Dufouil C, Ducimetière P, Alpérovitch A. Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA study group epidemiology of vascular aging. Neurology. 1999;53:1948–52. https://doi.org/10.1212/wnl.53.9.1948.CrossRefPubMed

27.

Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam study. Circulation. 2006;113:657–63. https://doi.org/10.1161/CIRCULATIONAHA.105.555235.CrossRefPubMed

28.

Raz N, Dahle CL, Rodrigue KM, Kennedy KM, Land S. Effects of age, genes, and pulse pressure on executive functions in healthy adults. Neurobiol Aging. 2011;32:1124–37. https://doi.org/10.1016/j.neurobiolaging.2009.05.015.CrossRefPubMed

29.

Sha T, Cheng W, Yan Y. Prospective associations between pulse pressure and cognitive performance in Chinese middle-aged and older population across a 5-year study period. Alzheimers Res Ther. 2018;10:29. https://doi.org/10.1186/s13195-018-0355-1.CrossRefPubMedPubMedCentral

30.

Hughes TM, Kuller LH, Barinas-Mitchell EJ, McDade EM, Klunk WE, Cohen AD, et al. Arterial stiffness and beta-amyloid progression in nondemented elderly adults. JAMA Neurol. 2014;71:562–8. https://doi.org/10.1001/jamaneurol.2014.186.CrossRefPubMedPubMedCentral

31.

Hughes TM, Wagenknecht LE, Craft S, Mintz A, Heiss G, Palta P, et al. Arterial stiffness and dementia pathology: Atherosclerosis Risk in Communities (ARIC)-PET Study. Neurology. 2018;90:e1248–56. https://doi.org/10.1212/WNL.0000000000005259.CrossRefPubMedPubMedCentral

32.

Hawkes CA, Sullivan PM, Hands S, Weller RO, Nicoll JA, Carare RO. Disruption of arterial perivascular drainage of amyloid-beta from the brains of mice expressing the human APOE epsilon4 allele. PLoS ONE. 2012;7:e41636. https://doi.org/10.1371/journal.pone.0041636.CrossRefPubMedPubMedCentral

33.

Cirrito JR, May PC, O’Dell MA, Taylor JW, Parsadanian M, Cramer JW, et al. In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life. J Neurosci. 2003;23:8844–53. https://doi.org/10.1523/JNEUROSCI.23-26-08844.2003.CrossRefPubMedPubMedCentral

Titel: Pulse pressure is associated with cognitive performance in Japanese non-demented population: a cross-sectional study
verfasst von: Ryo Mizuhara
Shingo Mitaki
Masahiro Takamura
Satoshi Abe
Keiichi Onoda
Shuhei Yamaguchi
Atsushi Nagai
Publikationsdatum: 01.12.2022
Verlag: BioMed Central
Erschienen in: BMC Neurology / Ausgabe 1/2022
Elektronische ISSN: 1471-2377
DOI: https://doi.org/10.1186/s12883-022-02666-6

Neu in den Fachgebieten Neurologie und Psychiatrie

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Delir bei kritisch Kranken – Antipsychotika versus Placebo

16.05.2024 Delir Nachrichten

Um die Langzeitfolgen eines Delirs bei kritisch Kranken zu mildern, wird vielerorts auf eine Akuttherapie mit Antipsychotika gesetzt. Eine US-amerikanische Forschungsgruppe äußert jetzt erhebliche Vorbehalte gegen dieses Vorgehen. Denn es gibt neue Daten zum Langzeiteffekt von Haloperidol bzw. Ziprasidon versus Placebo.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Pulse pressure is associated with cognitive performance in Japanese non-demented population: a cross-sectional study